Skip to content

Rip Road Capital Partners LP: RYM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Rip Road Capital Partners LP on RYM, newest first. How the timeline and the estimate are built.

Rip Road Capital Partners LP held 96,500 RYM shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 96,500 shares
    Change vs previous 13F 0 shares

    3.29% of the 13F portfolio, value $2,059,310.

    13F-HR 0001802893-26-000002 filed by Rip Road Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-09-30
    13F 96,500 shares
    Change vs previous 13F +15,083 shares

    4.26% of the 13F portfolio, value $3,956,500.

    13F-HR 0001802893-25-000007 filed by Rip Road Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 81,417 shares
    Change vs previous 13F +3,506 shares

    1.75% of the 13F portfolio, value $1,724,005.

    13F-HR 0001802893-25-000004 filed by Rip Road Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 77,911 shares
    Change vs previous 13F +10,528 shares

    1.5% of the 13F portfolio, value $1,367,338.

    13F-HR 0001802893-25-000003 filed by Rip Road Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 67,383 shares
    Change vs previous 13F not available

    1.65% of the 13F portfolio, value $1,953,433.

    13F-HR 0001802893-25-000002 filed by Rip Road Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).